Skip to main content Accessibility help
×
×
Home

Dietary intake of people with severe mental illness: systematic review and meta-analysis

  • Scott B. Teasdale (a1), Philip B. Ward (a2), Katherine Samaras (a3), Joseph Firth (a4), Brendon Stubbs (a5), Elise Tripodi (a6) and Tracy L. Burrows (a7)...
Abstract
Background

Severe mental illness (SMI) is thought to be associated with lower diet quality and adverse eating behaviours contributing towards physical health disparities. A rigorous review of the studies looking at dietary intake in psychotic disorders and bipolar disorder is lacking.

Aims

To conduct a systematic, comprehensive evaluation of the published research on dietary intake in psychotic disorders and bipolar disorder.

Method

Six electronic databases were searched for studies reporting on dietary intakes in psychotic disorders and bipolar disorder. Dietary-assessment methods, and dietary intakes, were systematically reviewed. Where possible, data was pooled for meta-analysis and compared with healthy controls.

Results

In total, 58 eligible studies were identified. People with SMI were found to have significantly higher dietary energy (mean difference 1332 kJ, 95% CI 487–2178 kJ/day, P = 0.002, g = 0.463) and sodium (mean difference 322 mg, 95% CI 174–490 mg, P < 0.001, g = 0.414) intake compared with controls. Qualitative synthesis suggested that higher energy and sodium intakes were associated with poorer diet quality and eating patterns.

Conclusions

These dietary components should be key targets for preventative interventions to improve weight and other physical health outcomes in people with SMI.

Declaration of interest

S.B.T. and E.T. have clinical dietitian appointments within the South Eastern Sydney Local Health District and do not receive any further funding.

Copyright
Corresponding author
Correspondence: Scott Teasdale, Keeping the Body in Mind Program, Bondi Community Centre, 26 Llandaff St, Bondi Junction, NSW 2022, Australia. Email: scott.teasdale@health.nsw.gov.au
References
Hide All
1Walker, ER, McGee, RE, Druss, BG. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry 2015; 72: 334–41.
2Thornicroft, G. Physical health disparities and mental illness: the scandal of premature mortality. Br J Psychiatry 2011; 199: 441–2.
3Correll, CU, Solmi, M, Veronese, N, Bortolato, B, Rosson, S, Santonastaso, P, et al. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry 2017; 16: 163–80.
4Gakidou, E, Afshin, A, Abajobir, AA, Abate, KH, Abbafati, C, Abbas, KM, et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016. Lancet 2017; 390: 1345–422.
5Lieberman, JA, Stroup, TS, McEvoy, JP, Swartz, MS, Rosenheck, RA, Perkins, DO, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005; 353: 1209–23.
6Galletly, CA, Castle, D, Dark, F, Humberstone, V, Jablensky, A, Killacky, E, et al. Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder. Aust N Z J Psychiatry 2016; 50: 1117.
7Álvarez-Jiménez, M, González-Blanch, C, Crespo-Facorro, B, Hetrick, S, Rodriguez-Sánchez, JM, Pérez-Iglasias, R, et al. Antipsychotic-induced weight gain in chronic and first-episode psychotic disorders. CNS Drugs 2008; 22: 547–62.
8Correll, CU, Manu, P, Olshanskiy, V, Napolitano, B, Kane, JM, Malhotra, AK. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA 2009; 302: 1765–73.
9Vancampfort, D, Stubbs, B, Mitchell, AJ, De Hert, M, Wampers, M, Ward, PB, et al. Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis. World Psychiatry 2015; 14: 339–47.
10Elman, I, Borsook, D, Lukas, SE. Food intake and reward mechanisms in patients with schizophrenia: implications for metabolic disturbances and treatment with second-generation antipsychotic agents. Neuropsychopharmacology 2006; 31: 2091–120.
11Blouin, M, Tremblay, A, Jalbert, ME, Venables, H, Bouchard, RH, Roy, MA, et al. Adiposity and eating behaviors in patients under second generation antipsychotics. Obesity 2008; 16: 1780–7.
12Dipasquale, S, Pariante, CM, Dazzan, P, Aguglia, E, McGuire, P, Mondelli, V. The dietary pattern of patients with schizophrenia: a systematic review. J Psychiatr Res 2013; 47: 197207.
13Stroup, DF, Berlin, JA, Morton, SC, Olkin, I, Williamson, GD, Rennie, D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 2000; 283: 2008–12.
14Moher, D, Liberati, A, Tetzlaff, J, Altman, TG, Altman, D, Antes, G, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009; 151: 264–9.
15Academy of Nutrition and Dietetics. Evidence Analysis Manual: Steps in the Academy Evidence Analysis Process. Evidence Analysis Library, 2016.
16Borenstein, M, Hedges, LV, Higgins, JPT, Rothstein, HR. Comprehensive Meta-Analysis Version 2: 104. Biostat, 2005.
17DerSimonian, R, Laird, N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177–88.
18Orwin, RG. A fail-safe N for effect size in meta-analysis. J Educ Stat 1983; 8: 157–9.
19Adolfo, AB, AhnAllen, CG, Tidey, JW. Effects of smoking cues on caffeine urges in heavy smokers and caffeine consumers with and without schizophrenia. Schizophr Res 2009; 107: 192–7.
20Amani, R. Is dietary pattern of schizophrenia patients different from healthy subjects? BMC Psychiatry 2007; 7: 15.
21Archie, SM, Goldberg, JO, Akhtar-Danesh, N, Landeen, J, McColl, L, McNiven, J. Psychotic disorders, eating habits, and physical activity: who is ready for lifestyle changes? Psychiatr Serv 2007; 58: 233–9.
22Arrojo-Romero, M, Armas Barbazán, C, López-Moriñigo, JD, Ramos-Rios, R, Gurpegui, M, Martinez-Ortega, JM, et al. Caffeine consumption in a long-term psychiatric hospital: tobacco smoking may explain in large part the apparent association between schizophrenia and caffeine use. Schizophr Res 2015; 164: 234–41.
23Baethge, C, Tondo, L, Lepri, B, Baldessarini, RJ. Coffee and cigarette use: association with suicidal acts in 352 Sardinian bipolar disorder patients. Bipolar Disord 2009; 11: 494503.
24Bly, MJ, Taylor, SF, Dalack, G, Pop-Busui, R, Burghardt, KJ, Evans, SJ, et al. Metabolic syndrome in bipolar disorder and schizophrenia: dietary and lifestyle factors compared to the general population. Bipolar Disord 2014; 16: 277–88.
25Bobes, J, Arango, C, Garcia-Garcia, M, Rejas, J. Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: an analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort. Schizophr Res 2010; 119: 101–9.
26Brown, S, Birtwistle, J, Roe, L, Thompson, C. The unhealthy lifestyle of people with schizophrenia. Psychol Med 1999; 29: 697701.
27Chang, YW, Assari, S, Prossin, AR, Stertz, L, McInnis, MG, Evans, SG. Bipolar disorder moderates associations between linoleic acid and markers of inflammation. J Psychiatr Res 2017; 85: 2936.
28Clayton, EH, Hanstock, TL, Hirneth, SJ, Kable, CJ, Garg, ML, Hazell, PL. Long-chain omega-3 polyunsaturated fatty acids in the blood of children and adolescents with juvenile bipolar disorder. Lipids 2008; 43: 1031–8.
29Ellingrod, VL, Taylor, SF, Brook, RD, Evans, SJ, Zölliner, SK, Grove, TB, et al. Dietary, lifestyle and pharmacogenetic factors associated with arteriole endothelial-dependent vasodilatation in schizophrenia patients treated with atypical antipsychotics (AAPs). Schizophr Res 2011; 130: 20–6.
30Elmslie, JL, Mann, JI, Silverstone, JT, Williams, SM, Romans, SE. Determinants of overweight and obesity in patients with bipolar disorder. J Clin Psychiatry 2001; 62: 486–91.
31Evans, SJ, Assari, S, Harrington, GJ, Chang, YW, Burant, CF, McInnis, MG. Plasma linoleic acid partially mediates the association of bipolar disorder on self-reported mental health scales. J Psychiatr Res 2015; 68: 61–7.
32Evans, SJ, Ringrose, RN, Harrington, GJ, Mancuso, P, Burant, CF, McInnis, MG. Dietary intake and plasma metabolomic analysis of polyunsaturated fatty acids in bipolar subjects reveal dysregulation of linoleic acid metabolism. J Psychiatr Res 2014; 57: 5864.
33Fawzi, MH, Fawzi, MM, Said, NS, Fawzi, MM, Fouad, AA, Abdel-Moety, H. Effect of Ramadan fasting on anthropometric, metabolic, inflammatory and psychopathology status of Egyptian male patients with schizophrenia. Psychiatry Res 2015; 225: 501–8.
34Fusar-Poli, P, De Marco, L, Cavallin, F, Bertorello, A, Nicolasi, M, Politi, P. Lifestyles and cardiovascular risk in individuals with functional psychoses. Perspect Psychiatr Care 2009; 45: 8799.
35Gothelf, D, Falk, B, Singer, P, Kairi, M, Philliip, M, Zigel, L, et al. Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine. Am J Psychiatry 2002; 159: 1055–7.
36Gupta, A, Craig, TK. Diet, smoking and cardiovascular risk in schizophrenia in high and low care supported housing. Epidemiol Psichiatr Soc 2009; 18: 200–7.
37Gurpegui, M, Aguilar, MC, Martinez-Ortega, JM, Diaz, FJ, de Leon, J. Caffeine intake in outpatients with schizophrenia. Schizophr Bull 2004; 30: 935–45.
38Gurpegui, M, Aguilar, MC, Martinez-Ortega, JM, Jurado, D, Diaz, FJ, Quintana, HM, et al. Fewer but heavier caffeine consumers in schizophrenia: a case-control study. Schizophr Res 2006; 86: 276–83.
39Hahn, LA, Galletly, CA, Foley, DL, Mackinnon, A, Watts, GF, Castle, DJ, et al. Inadequate fruit and vegetable intake in people with psychosis. Aust N Z J Psychiatry 2014; 48: 1025–35.
40Hamera, E, Schneider, JK, Deviney, S. Alcohol, cannabis, nicotine, and caffeine use and symptom distress in schizophrenia. J Nerv Ment Dis 1995; 183: 559–65.
41Hardy, S, Gray, R. The secret food diary of a person diagnosed with schizophrenia. J Psychiatr Ment Health Nurs 2012; 19: 603–9.
42Haruyuki, ITO, Kumagai, T, Kimura, M, Kolke, S, Shimizu, T. Dietary intake in body mass index differences in community-based Japanese patients with schizophrenia. Iranian J Public Health 2015; 44: 639–45.
43Heald, A, Pendlebury, J, Anderson, S, Narayan, V, Guy, M, Gibson, M, et al. Lifestyle factors and the metabolic syndrome in schizophrenia: a cross-sectional study. Ann Gen Psychiatry 2017; 16: 12.
44Henderson, DC, Borba, CP, Daley, TB, Boxill, R, Nguyen, DD, Culhane, MA, et al. Dietary intake profile of patients with schizophrenia. Ann Clin Psychiatry 2006; 18: 99105.
45Henderson, DC, Cagliero, E, Copeland, PM, Borba, CP, Evins, E, Hayden, D, et al. Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis. Arch Gen Psychiatry 2005; 62: 1928.
46Jacka, FN, Pasco, JA, Mykletun, A, Williams, LJ, Nicholson, GC, Kotowicz, MA, et al. Diet quality in bipolar disorder in a population-based sample of women. J Affect Disord 2011; 129: 332–7.
47Jahrami, HA, Faris, MAE, Saif, ZQ, Hammad, LH. Assessing dietary and lifestyle risk factors and their associations with disease comorbidities among patients with schizophrenia: a case-control study from Bahrain. Asian J Psychiatr 2017; 28: 115–23.
48Kilbourne, AM, Rofey, DL, McCarthy, JF, Post, EP, Welsh, D, Blow, FC. Nutrition and exercise behavior among patients with bipolar disorder. Bipolar Disord 2007; 9: 443–52.
49Kilian, R, Becker, T, Krüger, L, Schmid, S, Frasch, K. Health behavior in psychiatric in-patients compared with a German general population sample. Acta Psychiatr Scand 2006; 114: 242–8.
50Konarzewska, B, Stefańska, E, Wendolowicz, A, Cwalina, U, Golonko, A, Malus, A, et al. Visceral obesity in normal-weight patients suffering from chronic schizophrenia. BMC Psychiatry 2014; 14: 35.
51Manzanares, N, Monseny, R, Ortega, L, Montalvo, I, Franch, J, Gutliérrez-Zotes, A, et al. Unhealthy lifestyle in early psychoses: the role of life stress and the hypothalamic-pituitary-adrenal axis. Psychoneuroendocrinology 2014; 39: 110.
52McCreadie, RG, Scottish Schizophrenia Lifestyle Group. Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study. Br J Psychiatry 2003; 183: 534–9.
53Mucheru, D, Hanlon, MC, Campbell, LE, McEvoy, M, MacDonald-Wicks, L. Social dysfunction and diet outcomes in people with psychosis. Nutrients 2017; 9: 80.
54Nenke, MA, Hahn, LA, Thompson, CH, Liu, D, Galletly, CA. Psychosis and cardiovascular disease: is diet the missing link? Schizophr Res 2015; 161: 465–70.
55Nunes, D, Eskinazi, B, Cambolm Rockett, F, Delgado, VB, Schwelgert Perry, ID. Nutritional status, food intake and cardiovascular disease risk in individuals with schizophrenia in southern Brazil: a case-control study. Rev Psiquiatr Salud Ment 2014; 7: 72–9.
56Osborn, DP, Nazareth, I, King, MB. Physical activity, dietary habits and coronary heart disease risk factor knowledge amongst people with severe mental illness. Soc Psychiatry Psychiatr Epidemiol 2007; 42: 787–93.
57Ratliff, JC, Palmese, LB, Reutenauer, EL, Liskov, E, Grilo, CM, Tek, C. The effect of dietary and physical activity pattern on metabolic profile in individuals with schizophrenia: a cross-sectional study. Compr Psychiatry 2012; 53: 1028–33.
58Roick, C, FritzWieacker, A, Matschinger, H, Heider, D, Schindler, J, Riedel-Heller, S, et al. Health habits of patients with schizophrenia. Soc Psychiatry Psychiatr Epidemiol 2007; 42: 268–76.
59Ryan, MC, Flanagan, S, Kinsella, U, Keeling, F, Thakore, JH. The effects of atypical antipsychotics on visceral fat distribution in first episode, drug-naive patients with schizophrenia. Life Sci 2004; 74: 19992008.
60Ryan, MCM, Collins, P, Thakore, JH. Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatry 2003; 160: 284–9.
61Saarni, S, Saarni, SI, Fogelholm, M, Fogelholm, M, Heliövaara, M, Perälä, J, Suvisaari, J, et al. Body composition in psychotic disorders: a general population survey. Psychol Med 2009; 39: 801–10.
62Samele, C, Patel, M, Boydell, J, Leese, M, Wessely, S, Murray, R. Physical illness and lifestyle risk factors in people with their first presentation of psychosis. Soc Psychiatry Psychiatr Epidemiol 2007; 42: 117–24.
63Simonelli-Muñoz, AJ, Fortea, MI, Salorio, P, Gallego-Gomez, JI, Sánchez-Bautista, S, Balanza, S. Dietary habits of patients with schizophrenia: a self-reported questionnaire survey. Int J Ment Health Nurs 2012; 21: 220–8.
64Stokes, C, Peet, M. Dietary sugar and polyunsaturated fatty acid consumption as predictors of severity of schizophrenia symptoms. Nutr Neurosci 2004; 7: 247–9.
65Strassnig, M, Singh Brar, J, Ganguli, R. Nutritional assessment of patients with schizophrenia: a preliminary study. Schizophr Bull 2003; 29: 393–7.
66Strassnig, M, Singh Brar, J, Ganguli, R. Increased caffeine and nicotine consumption in community-dwelling patients with schizophrenia. Schizophr Res 2006; 86: 269–75.
67Strassnig, M, Singh Brar, J, Ganguli, R. Dietary fatty acid and antioxidant intake in community-dwelling patients suffering from schizophrenia. Schizophr Res 2005; 76: 343–51.
68Sugawara, N, Yasui-Furukori, N, Sato, Y, Saito, M, Furukori, H, Nakagami, T, et al. Dietary patterns are associated with obesity in Japanese patients with schizophrenia. BMC Psychiatry 2014; 14: 184.
69Sugawara, N, Yasui-Furukori, N, Yamazaki, M, Shimoda, K, Mori, T, Sugai, T, et al. Attitudes toward metabolic adverse events among patients with schizophrenia in Japan. Neuropsychiatr Dis Treat 2016; 12: 427–36.
70Suvisaari, JM, Saarni, SI, Perälä, J, Suvisaari, JV, Härkänen, T, Lönnqvist, J, et al. Metabolic syndrome among persons with schizophrenia and other psychotic disorders in a general population survey. J Clin Psychiatry 2007; 68: 1045–55.
71Treuer, T, Hoffman, VP, Chen, AK, Irimia, V, Ocampo, M, Wang, G, et al. Factors associated with weight gain during olanzapine treatment in patients with schizophrenia or bipolar disorder: results from a six-month prospective, multinational, observational study. World J Biol Psychiatry 2009; 10: 729–40.
72Tsuruga, K, Sugawara, N, Sato, Y, Saito, M, Furukori, H, Nakagami, T, et al. Dietary patterns and schizophrenia: a comparison with healthy controls. Neuropsychiatr Dis Treat 2015; 11: 1115–20.
73Wallace, B, Tennant, C. Nutrition and obesity in the chronic mentally ill. Aust N Z J Psychiatry 1998; 32: 82–5.
74Williamson, K, Kilner, K, Clibbens, N. A comparison of the nutrient intake of a community-dwelling first-episode psychosis cohort, aged 19-64 years, with data from the UK population. J Nutr Sci 2015; 4: e28.
75Winstead, DK. Coffee consumption among psychiatric inpatients. Am J Psychiatry 1976; 133: 1447–50.
76Noguchi, R, Hiraoka, M, Watanabe, Y, Kagawa, Y. Relationship between dietary patterns and depressive symptoms: difference by gender, and unipolar and bipolar depression. J Nutr Sci Vitaminol 2013; 59: 115–22.
77Archie, SM, Goldberg, JO, Akhtar-Danesh, N, Landeen, J, McColl, L, McNiven, J. Psychotic disorders, eating habits, and physical activity: who is ready for lifestyle changes? Psychiatr Serv 2007; 58: 233–9.
78Duffey, KJ, Popkin, BM. Energy density, portion size, and eating occasions: contributions to increased energy intake in the United States, 1977–2006. PLoS Med 2011; 8: e1001050.
79Appel, LJ, Frohlich, ED, Hall, JE, Pearson, TA, Sacco, RL, Seals, DR, et al. The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association. Circulation 2011; 123: 1138–43.
80Vancampfort, D, Firth, J, Schuch, FB, Rosenbaum, S, Mugisha, J, Hallgren, M, et al. Sedentary behavior and physical activity levels in people with schizophrenia, bipolar disorder and major depressive disorder: a global systematic review and meta-analysis. World Psychiatry 2017; 16: 308–15.
81Vancampfort, D, Rosenbaum, S, Schuch, FB, et al. Cardiorespiratory fitness in severe mental illness: a systematic review and meta-analysis. Sports Med 2017; 47: 343–52.
82Hall, KD, Heymsfield, SB, Kemnitz, JW, Klein, S, Schoeller, DA, Speakman, JR. Energy balance and its components: implications for body weight regulation. Am J Clin Nutr 2012; 95: 989–94.
83Werneke, U, Taylor, D, Sanders, TAB. Behavioral interventions for antipsychotic induced appetite changes. Curr Psychiatry Rep 2013; 15: 347.
84Lett, TA, Wallace, TJ, Chowdhury, NI, Tiwari, AK, Kennedy, JL, Müller, DJ. Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications. Mol Psychiatry 2012; 17: 242–66.
85Reynolds, GP, Kirk, SL. Metabolic side effects of antipsychotic drug treatment–pharmacological mechanisms. Pharmacol Ther 2010; 125: 169–79.
86Mitchell, AJ, Vancampfort, D, Sweers, K, van Winkel, R, Yu, K, De Hert, M. Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders—a systematic review and meta-analysis. Schizophr Bull 2011; 39: 306–18.
87Firth, J, Carney, R, Stubbs, B, Teasdale, SB, Vancampfort, D, Ward, PB, et al. Nutritional deficiencies and clinical correlates in first-episode psychosis: a systematic review and meta-analysis. Schizophr Bull 2018; 44: 1275–92.
88Burrows, TL, Williams, R, Rollo, M, Wood, L, Garg, ML, Jensen, M, et al. Plasma carotenoid levels as biomarkers of dietary carotenoid consumption: a systematic review of the validation studies. J Nutr Intermed Metab, 2015; 2: 1564.
89Hill, RJ, Davies, PSW. The validity of self-reported energy intake as determined using the doubly labelled water technique. Br J Nutr 2001; 85: 415–30.
90Lally, J, Ajnakina, O, Stubbs, B, Cullinane, M, Murphy, KC, Gaughran, F, et al. Remission and recovery from first-episode psychosis in adults: systematic review and meta-analysis of long-term outcome studies. Br J Psychiatry, 2017; 211: 350–8.
91Fountaine, RJ, Taylor, AE, Mancuso, JP, Greenway, FL, Byerley, LO, Smith, SR, et al. Increased food intake and energy expenditure following administration of olanzapine to healthy men. Obesity 2010; 18: 1646–51.
92Teasdale, SB, Ward, PB, Rosenbaum, S, Samaras, K, Stubbs, B. Solving a weighty problem: systematic review and meta-analysis of nutrition interventions in severe mental illness. Br J Psychiatry 2017; 210: 110–8.
93Quirk, SE, Williams, LJ, O'Neil, A, Pasco, JA, Jacka, FN, Housden, S, et al. The association between diet quality, dietary patterns and depression in adults: a systematic review. BMC Psychiatry 2013; 13: 175.
94Jacka, FN, O'Neil, A, Opie, R, Itsiopoulos, C, Cotton, S, Mohebbi, M, et al. A randomised controlled trial of dietary improvement for adults with major depression (the ‘SMILES'trial). BMC Med 2017; 15: 23.
95Opie, RS, O'Neil, A, Jacka, FN, Pizzinga, J, Itsiopoulos, C. A modified Mediterranean dietary intervention for adults with major depression: dietary protocol and feasibility data from the SMILES trial. Nutr Neurosci 2018; 21: 487501.
96Cherbuin, N, Sachdev, P, Anstey, KJ. Higher normal fasting plasma glucose is associated with hippocampal atrophy The PATH Study. Neurology 2012; 79: 1019–26.
97Jacka, FN, Cherbuin, N, Anstey, KJ, Sachdev, P, Butterworth, P. Western diet is associated with a smaller hippocampus: a longitudinal investigation. BMC Med 2015; 13: 215.
98Psaltopoulou, T, Sergentanis, TN, Panagiotakos, DB, Sergentanis, IN, Kosti, R, Scarmeas, N. Mediterranean diet, stroke, cognitive impairment, and depression: a meta-analysis. Ann Neurol 2013; 74: 580–91.
99Shim, JS, Oh, K, Kim, HC. Dietary assessment methods in epidemiologic studies. Epidemiol Health 2014; 36: e2014009.
100Lachat, C, Hawwash, D, Ockè, MC, Berg, C, Forsum, E, Hörnell, A, et al. Strengthening the Reporting of Observational Studies in Epidemiology–nutritional epidemiology (STROBE-nut): an extension of the STROBE statement. Nutr Bull 2016; 41: 240–51.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The British Journal of Psychiatry
  • ISSN: 0007-1250
  • EISSN: 1472-1465
  • URL: /core/journals/the-british-journal-of-psychiatry
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords

Type Description Title
UNKNOWN
Supplementary materials

Teasdale et al. supplementary material
Teasdale et al. supplementary material 1

 Unknown (614 KB)
614 KB

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Dietary intake of people with severe mental illness: systematic review and meta-analysis

  • Scott B. Teasdale (a1), Philip B. Ward (a2), Katherine Samaras (a3), Joseph Firth (a4), Brendon Stubbs (a5), Elise Tripodi (a6) and Tracy L. Burrows (a7)...
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *